Cite
Jain P, Zhao S, Lee HJ, et al. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. J Clin Oncol. 2021;JCO2101797doi: 10.1200/JCO.21.01797.
Jain, P., Zhao, S., Lee, H. J., Hill, H. A., Ok, C. Y., Kanagal-Shamanna, R., Hagemeister, F. B., Fowler, N., Fayad, L., Yao, Y., Liu, Y., Moghrabi, O. B., Navsaria, L., Feng, L., Nogueras Gonzalez, G. M., Xu, G., Thirumurthi, S., Santos, D., Iliescu, C., Tang, G., Medeiros, L. J., Vega, F., Avellaneda, M., Badillo, M., Flowers, C. R., Wang, L., & Wang, M. L. (2021). Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2101797. https://doi.org/10.1200/JCO.21.01797
Jain, Preetesh, et al. "Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2101797. doi: https://doi.org/10.1200/JCO.21.01797
Jain P, Zhao S, Lee HJ, Hill HA, Ok CY, Kanagal-Shamanna R, Hagemeister FB, Fowler N, Fayad L, Yao Y, Liu Y, Moghrabi OB, Navsaria L, Feng L, Nogueras Gonzalez GM, Xu G, Thirumurthi S, Santos D, Iliescu C, Tang G, Medeiros LJ, Vega F, Avellaneda M, Badillo M, Flowers CR, Wang L, Wang ML. Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. J Clin Oncol. 2021 Nov 19;JCO2101797. doi: 10.1200/JCO.21.01797. Epub 2021 Nov 19. PMID: 34797699; PMCID: PMC8718245.
Copy
Download .nbib